Healthcare & Life Sciences Private Equity Deal Tracker: Windjammer Acquires Bio X Cell
JD Supra: Mergers
DECEMBER 27, 2023
Windjammer Capital has announced it has acquired Bio X Cell (BXC). BXC, founded in 1997 and based in Lebanon, N.H., is a producer of monoclonal antibodies for use in both in vivo and in vitro pre-clinical research applications. By: McGuireWoods LLP
Let's personalize your content